Role of IL-6 and IL-6 targeted therapy in systemic lupus erythematosus

被引：7
|
作者：
Nepal, Desh [1 ,2 ]
Gazeley, David [1 ]
机构：
[1] Med Coll Wisconsin, Dept Med, Div Rheumatol, Milwaukee, WI USA
[2] Med Coll Wisconsin, Rheumatol, Hub Collaborat Med, 8701 Watertown Plan Rd,6th Floor, Milwaukee, WI 53226 USA
来源：
RHEUMATOLOGY | 2023年 / 62卷 / 12期
关键词：
IL-6; inhibition; SLE; tocilizumab; sirukumab; OF-RHEUMATOLOGY GUIDELINE; PHASE PROTEIN RESPONSE; MONOCLONAL-ANTIBODY; DISEASE-ACTIVITY; MURINE LUPUS; T-CELLS; INTERLEUKIN-6; TOCILIZUMAB; EFFICACY; RECEPTOR;
D O I：
10.1093/rheumatology/kead416
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Interleukin-6 is one of the cytokines implicated in murine and human SLE. Only a few small studies have investigated IL-6 inhibition in human SLE. Currently, there are no studies registered in clinicaltrials.gov to assess the IL-6 targeted therapy in SLE, yet its role in the future remains to be defined. This narrative review analyses these and potential areas of future studies with IL-6 targeted therapy in SLE. A video abstract is available for this article and can be viewed at https://doi.org/10.1093/rheumatology/kead416.
引用
收藏
页码：3804 / 3810
页数：7
相关论文
共 50 条
  • [31] Tocilizumab Therapy for Treatment-Resistant Systemic Lupus Erythematosus with Elevated IL-6 and CRP Levels: a Case Report
    Sandeep Yadav
    Vishnu Sharma
    C. Balakrishnan
    SN Comprehensive Clinical Medicine, 5 (1)
  • [32] SERUM-SOLUBLE INTERLEUKIN-6 (IL-6) RECEPTOR AND IL-6 SOLUBLE IL-6 RECEPTOR COMPLEX IN SYSTEMIC JUVENILE RHEUMATOID-ARTHRITIS
    DEBENEDETTI, F
    MASSA, M
    PIGNATTI, P
    ALBANI, S
    NOVICK, D
    MARTINI, A
    JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (05): : 2114 - 2119
  • [33] Investigating the role of IL-6 in the pathogenesis of systemic lupus erythematosus: Insights from bone marrow mesenchymal stem cells
    Zhang, Zhiwen
    Zhu, Silang
    Li, Qian
    Wei, Shanshan
    Yin, Li
    Zhu, Junhao
    Yang, Shan
    Zhang, Wenjing
    Lai, Kuan
    LUPUS, 2025,
  • [34] Minimal Interleukin 6 (IL-6) Receptor Stalk Composition for IL-6 Receptor Shedding and IL-6 Classic Signaling
    Baran, Paul
    Nitz, Rebecca
    Groetzinger, Joachim
    Scheller, Juergen
    Garbers, Christoph
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (21) : 14756 - 14768
  • [35] Investigating the role of IL-6 in the pathogenesis of systemic lupus erythematosus: Insights from bone marrow mesenchymal stem cells
    Zhang, Zhiwen
    Zhu, Silang
    Li, Qian
    Wei, Shanshan
    Yin, Li
    Zhu, Junhao
    Yang, Shan
    Zhang, Wenjing
    Lai, Kuan
    LUPUS, 2025, 34 (03) : 225 - 233
  • [36] INTERLEUKIN-6 (IL-6) AND ACUTE PHASE PROTEINS IN THE DISEASE COURSE OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    SWAAK, AJG
    VANROOYEN, A
    AARDEN, LA
    RHEUMATOLOGY INTERNATIONAL, 1989, 8 (06) : 263 - 268
  • [37] Induction of atypical EAE mediated by transgenic production of IL-6 in astrocytes in the absence of systemic IL-6
    Giralt, Mercedes
    Ramos, Raquel
    Quintana, Albert
    Ferrer, Beatriz
    Erta, Maria
    Castro-Freire, Marco
    Comes, Gemma
    Sanz, Elisenda
    Unzeta, Mercedes
    Pifarre, Paula
    Garcia, Agustina
    Campbell, Iain L.
    Hidalgo, Juan
    GLIA, 2013, 61 (04) : 587 - 600
  • [38] INTERLEUKIN-6 (IL-6) AUTOANTIBODIES AND BLOOD IL-6 MEASUREMENTS
    HANSEN, MB
    SVENSON, M
    DIAMANT, M
    ROSS, C
    BENDTZEN, K
    BLOOD, 1995, 85 (04) : 1145 - 1145
  • [39] The role of soluble IL-6 receptor in mediating the effects of IL-6 on collagenolytic activity.
    Irwin, CR
    Myrillas, TT
    Traynor, P
    Leadbetter, N
    Cawston, T
    JOURNAL OF DENTAL RESEARCH, 2002, 81 : A124 - A124
  • [40] A greater variability in the 3' flanking region of the IL-6 gene in patients with systemic lupus erythematosus (SLE)
    LinkerIsraeli, M
    Wallace, DJ
    Prehn, JL
    Nand, R
    Li, L
    Klinenberg, JR
    AUTOIMMUNITY, 1996, 23 (03) : 199 - 209
12345